North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.115

+3.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don W Stone who wrote (1)	9/27/1996 3:55:00 PM
From: Nidarius Foxworth	of 82

Don, The portfolio in question is run by a newsletter called Sturza's Medical Investment Letter. The portfolio is a "paper" portfolio with the sole purpose of monitoring the performance of the recommendations which the Medical Investment Letter makes. It is clear to me that the portfolio is NOT covering any of its NVX short position. On the contrary, the portfolio placed a GTC order to Short another 4% at $27. If the order goes through, it will bring the total NVX short position to 20%. But, if you have any questions why not call the publishers yourself? Sturza's Medical Investment Letter is based in New York and the telephone number is 212-541-8200. An interesting note: Some of Sturza's NVX material can be read at www.westergaard.com Question: Is your astute friend of yours the same person who is helping you with information on NVX? If so, maybe we should do a little fact checking. Keepin' the dialog going... N.F.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next